ArticleInfectious diseases and therapy2026
Rise of Lower Respiratory Tract Infections Other than Respiratory Syncytial Virus in the Emergency Room: Results from the Season (2024/25) of the RISE Study.
Article in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAcute respiratory infections (ARI) are a major cause of pediatric emergency department (ED) visits and hospitalizations. Although respiratory syncytial virus (RSV), influenza, and rhinovirus (RV) are common etiological agents, pathogen-specific data from pediatric emergency settings remain limited.
methodsThis prospective surveillance study quantified ARI-related ED visits, described pathogen-specific epidemiology, and assessed attendance and hospitalization rates as well as the distribution of lower versus upper respiratory tract infections (LRTI/URTI) in children younger than 60 months in two pediatric EDs in Berlin between November 1, 2024 and May 31, 2025. Respiratory pathogens were identified using nasopharyngeal swab samples tested by multiplex real-time RT-PCR (QIAstat-Dx
resultsWithin the study period 4042 ARI-related ED visits occurred. A total of 310 children were enrolled in our study (median age 18 months); 115 (37.1%) had LRTI and 195 (62.9%) URTI. At least one respiratory pathogen was detected in 271 children (87.4%). The attendance rate for RSV was 24.4% (66 cases), for FLU 25.8% (70 cases), and for RV 29.5% (80 cases). Overall, 93 children (30.0%) were hospitalized, including 65 with LRTI and 28 with URTI. Hospitalization rates were highest for RSV infections (26/65, 40.0%) and RV infections (28/65, 43.1%), and lower for FLU infections (13/69, 18.8%). Hospitalization due to LRTI predominated among children with RSV (24/26, 92.3%) and RV infections (20/28, 71.4%), whereas FLU infections were less frequently observed (7/13, 53.9%). Furthermore, younger age, a history of pneumonia, a history of bronchiolitis, and the absence of breastfeeding were associated with hospitalization.
conclusionsIn contrast to the previous season, in which RSV was associated with the highest attendance and hospitalization rate, we observed a high burden of RV infections in the 2024/2025 season. These findings may impact surveillance strategies, clinical management, and future public health strategies.
Indexed as
Identifiers
42909577What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.